Literature DB >> 6250514

Studies on poxvirus infections in irradiated animals.

G T Werner, U Jentzsch, E Metzger, J Simon.   

Abstract

If rabbits were given total body irradiation and infected wih vaccinia virus (strain Elstree) a severe disease developed with a viraemia lasting up to 12 days. The clearance of the virus from the peripheral blood was severely impaired by x-ray doses above 800 R. The attenuated vaccinia virus strain MV did not turn virulent, if it was injected to irradiated rabbits. With caution it can be assumed that live vaccines, containing attenuated viruses, may be given to immunosuppressed persons. Rats are not susceptible to ectromelia-virus (mouse-poxvirus); overt clinical sympatoms, however, with a mortality of 30 per cent developed in irradiated rats. This proofs that specific poxviruses can be transferred to another species. As the experimental conditions are unnatural, this may occur only rarely in immunosuppressed persons. After intracerebral infection of Balb-C-mice with low doses of vaccinia virus two types of infection were seen: 1. a severe cytocidal infection of leptomeninges, chorioid plexus and vessels; 2. a noncytocidal, latent infection of glial cells and neurons. Several animals developed a picture resembling experimental allergic encephalomyelitis. It seems that irradiation altered the antigenic conditions of the cytoplasmic membranes in non-cytocidally infected cells. The model might explain some processes in the pathogenesis of demylinating diseases.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6250514     DOI: 10.1007/bf01322704

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  13 in total

1.  [An attenuated strain of vaccinia virus (MVA). Successful intramuscular immunization against vaccinia and variola (author's transl)].

Authors:  V Hochstein-Mintzel; T Hänichen; H C Huber; H Stickl
Journal:  Zentralbl Bakteriol Orig A       Date:  1975

2.  Immunopathology of mouse hepatitis virus type 3mii. effect of immunosuppression in resistant mice.

Authors:  J M Dupuy; E Levey-Leblond; C Le Prevost
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

3.  Differential effects of sublethal irradiation on the humoral immune responses of adult and neonatal mice.

Authors:  J Quintáns; D Kaplan
Journal:  Cell Immunol       Date:  1978-09-15       Impact factor: 4.868

4.  [Increased immunogenicity of plasma membranes of BHK-cells infected by vaccinia virus].

Authors:  G Bandlow; U Koszinowski; R Thomssen
Journal:  Arch Gesamte Virusforsch       Date:  1973

5.  Increase in preexisting cellular antigen-combining groups at different times after infection with different viruses.

Authors:  G Tarro; A B Sabin
Journal:  Proc Natl Acad Sci U S A       Date:  1970-10       Impact factor: 11.205

6.  Comparative studies on the properties of variola virus strains. II. Pathogenicity for suckling mice and gamma-irradiated adult white mice.

Authors:  R A Shafikova; S S Marennikova
Journal:  Acta Virol       Date:  1971-07       Impact factor: 1.162

7.  "Vaccinial disease" of mice.

Authors:  I A Svet-Moldavskaya; K L Chimishkyan
Journal:  Acta Virol       Date:  1969-11       Impact factor: 1.162

8.  [MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)].

Authors:  H Stickl; V Hochstein-Mintzel; A Mayr; H C Huber; H Schäfer; A Holzner
Journal:  Dtsch Med Wochenschr       Date:  1974-11-22       Impact factor: 0.628

9.  A specific surface antigen induced by poxvirus.

Authors:  Y Ueda; M Ito; I Tagaya
Journal:  Virology       Date:  1969-05       Impact factor: 3.616

10.  Experimental vaccinia virus meningoencephalitis in adult albino mice: virological, light microscopic and ultrastructural studies.

Authors:  K Blinzinger; V Hochstein-Mintzel; A P Anzil
Journal:  Acta Neuropathol       Date:  1977-11-28       Impact factor: 17.088

View more
  13 in total

1.  Depression of protective mechanism during the early phase of a viral infection in tumor-bearing mice and prevention by PSK.

Authors:  S Tsuru; K Nomoto; M Taniguchi; H Fujisawa; Y Zinnaka
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine.

Authors:  J C Ramírez; M M Gherardi; M Esteban
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 3.  Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates.

Authors:  B Moss; M W Carroll; L S Wyatt; J R Bennink; V M Hirsch; S Goldstein; W R Elkins; T R Fuerst; J D Lifson; M Piatak; N P Restifo; W Overwijk; R Chamberlain; S A Rosenberg; G Sutter
Journal:  Adv Exp Med Biol       Date:  1996       Impact factor: 2.622

4.  Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.

Authors:  Lewis H McCurdy; John A Rutigliano; Teresa R Johnson; Man Chen; Barney S Graham
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

5.  Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy.

Authors:  A P Durbin; M H Skiadopoulos; J M McAuliffe; J M Riggs; S R Surman; P L Collins; B R Murphy
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza.

Authors:  B S Bender; C A Rowe; S F Taylor; L S Wyatt; B Moss; P A Small
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

7.  Immune requirements of post-exposure immunization with modified vaccinia Ankara of lethally infected mice.

Authors:  Henning Lauterbach; Ronny Kassub; Juliane Pätzold; Jana Körner; Michael Brückel; Admar Verschoor; Paul Chaplin; Mark Suter; Hubertus Hochrein
Journal:  PLoS One       Date:  2010-03-11       Impact factor: 3.240

8.  Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.

Authors:  Simone Hornemann; Olof Harlin; Caroline Staib; Sigrid Kisling; Volker Erfle; Bernd Kaspers; Georg Häcker; Gerd Sutter
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

Review 9.  Poxvirus pathogenesis.

Authors:  R M Buller; G J Palumbo
Journal:  Microbiol Rev       Date:  1991-03

10.  Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines.

Authors:  Zhongde Wang; Joy Martinez; Wendi Zhou; Corinna La Rosa; Tumul Srivastava; Anindya Dasgupta; Ravindra Rawal; Zhongqui Li; William J Britt; Don Diamond
Journal:  Vaccine       Date:  2009-12-05       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.